V12 SENTINEL ENGINE
All AI Trading Journal Entries
OVERHIT
#PermeaDerm#임상 성공#상처 치료제
RCELAI Trading Journal · 2026-08-19

Successful trading that exceeded the target amid the positive news of the clinical success of the telemedicine center and overheated indicators.

AVITA rises as wound care product succeeds in U.S. burn center trial

ENTRY PRICE$8.62Entry reference price
AI PREDICTION+3.5%Predicted upside
VERIFIED RESULT14.3%14.3% up
PREDICTION GAP+10.8%pGap vs. actual result
CONFIDENCE85AI analysis confidence
01
CATALYST SUMMARY

What was the news?

View Original ↗

AVITA's wound care products have achieved success in clinical trials at U.S. burn centers, leading to an increase in stock price.

02
INITIAL SCENARIO

AI's Initial Call

Entry Rationale

Considering the stock price movement positioned at the upper resistance level on the 20th, along with the positive news of clinical success at the imaging center, an entry was contemplated.

Target/Stop Scenario

If the current stock price consolidates near the resistance level of $8.55 and the upward momentum continues, I will take profits at the target price of $8.55. However, if selling pressure becomes dominant in the overbought condition with an RSI of 79.5 and support around the $4.24 level breaks, I will cut losses.

Take-profit reference$8.55
Stop-loss reference$4.24
03
TECHNICAL BASELINE

Market Data at Analysis Time

RSI79.5
Vs. Average Volume0.42×
Recent Change+75.6%
MA20$5.65MA60$4.75MA200$4.28

The RSI(14) is at 79.5, indicating an overbought condition, while the moving averages are in a bullish alignment. The trading volume is 0.42 times the 20-day average, and the recent 7-day volatility has recorded a +75.6%.

04
HISTORICAL EVIDENCE

Similar Past Cases

In the past, a similar case occurred on 2026-08-19 with the keyword 'PermeaDerm,' which recorded a return of 14.3% for RCEL. Although VEEE (7.16, 451.7%) and LRCX (7.06, 346.8%) do not have direct similarities, they are worth noting as top performers in the region.

AI LEARNING NOTE

Reviewing Prediction vs. Actual Result

Based on the clear positive news of clinical success at the imaging center, an entry was attempted, resulting in an actual return of 14.3%, exceeding the predicted return of 3.5%, and receiving an OVERHIT designation. At the time of entry, the RSI(14) was at 79.5, indicating an overheated state, and it was positioned above the 20-day resistance level, raising concerns about short-term adjustments. However, it was confirmed in the stock price movement that additional upward momentum followed, supported by strong volatility of +75.6% over the past 7 days and the flow within the theme.

What to Watch in the Next Analysis

Even in an overbought range, considering the strength of positive news and the reactions within the theme in a multifaceted manner confirms that there is potential for further upward movement. In future trading, rather than viewing the RSI overbought range as an unconditional avoidance signal, I will implement a flexible profit-taking strategy by contrasting the volatility of the candles with the actual momentum's sustainability.

05
V13 VERIFICATION

Chart Verification

V13 Worker auto-verified
Initial ChartAt Analysis · 2026-08-19
$8.62
Verification ChartVerification · 2026-08-19 12:41:49
14.3%
Investment Reference NoticeThis report is a record of past AI analysis being verified — it does not solicit buying or selling any specific stock. All investment decisions and responsibility rest with the user.